Highlights from DDW 2025
DAY 3 - AGA Hosts the Late-Breaking Clinical Science Plenary
Early Monday morning, the Clinical Science Plenary featured results from trials expected to advance clinical practice and technology across an array of GI conditions.
May 14th, 2025
Read more
DAY 3 - Highlights of the 2025 AGA Clinical Guidelines and an Invitation to Comment
In a Tuesday morning session, the authors of three newly published and upcoming AGA guidelines reviewed their approach to evidence synthesis and findings and implications for clinical practice.
May 14th, 2025
Read more
DAY 3 - Evaluating the Costs and Benefits of Implementing Guideline Recommendations for Common GI Disorders
A Tuesday afternoon session focused on studies evaluating the effectiveness and costs of current guideline recommendations, compared conflicting guidelines recommendations, and described tools to help physicians parse through rapidly changing guideline recommendations across various GI disorders.
May 14th 2025
Read more
DAY 3 - The Future of Microbiome Therapeutics: Bright or Bleak?
On Tuesday afternoon, three panelists discussed the successes and challenges facing the development of microbiome therapeutics, including therapeutics for allergic diseases and new targets.
May 14th, 2025
Read moreMore Summaries
DAY 1 - Advances in Understanding and Managing IBD: Global Trends, Genetic Insights, and Emerging Therapies
At the Farron and Martin Brotman, MD, Lecture on Sunday morning, titled IBD in 2025: Reviewing a Quarter Century of Progress, speakers reviewed trends in IBD epidemiology, insights into disease mechanisms at the genetic and cellular level, the role of the microbiome, and the changing landscape of disease monitoring and treatment.
May 12th, 2025
Read more
DAY 1 - Addressing Health Disparities in Native American and Alaskan Native Populations: CRC and Liver Disease Insights and Interventions
A Sunday afternoon session focused on approaches to reduce disparities and improve GI care among Native Americans, Alaskan Natives, and other underrepresented minorities.
May 12th, 2025
Read more
DAY 1 - Challenges and Innovations in Gastroenterology: Screening Barriers, Gender Disparities, Financial Trends, and AI-Driven Patient Education
In a clinical research session on Sunday afternoon, speakers discussed challenges and opportunities in the evolving landscape of gastroenterology, including gender equity and pay gaps, revenue erosion, the trend toward private equity acquisitions, and new uses of AI for multi-lingual patient education.
May 12th, 2025
Read more
DAY 2 - AGA Annual “Battle of the Heavyweights” to Debate Hot Topics in Clinical Care
In a Sunday morning session, AGA’s clinical “heavyweights” debated three clinical topics: Should GLP-1 RA be stopped prior to endoscopy? Should portal vein thrombosis be anticoagulated? And Are PPIs sufficient in clinical medicine and PCABs not needed? The audience was invited to weigh in on who “won” the debate.
May 13th, 2025
Read more
DAY 2 - Should portal vein thrombosis be anticoagulated?
In a heated debate, Dr. Fadi Francis from the American University of Beirut Faculty of Medicine advocates for anticoagulation in patients with portal vein thrombosis (PVT) and cirrhosis, citing studies that highlight its benefits in reducing progression and improving survival rates. On the other hand, Dr. Joseph K. Lim from Yale University argues against routine anticoagulation, emphasizing the risks and the need for a selective approach. Discover the compelling arguments from both sides and the surprising audience poll results.
May 13th, 2025
Read more
DAY2 - Are PPIs sufficient in clinical medicine and PCABs not needed?
In a compelling debate, Dr. Loren Laine from Yale University argues that proton pump inhibitors (PPIs) are sufficient for clinical use, highlighting their cost-effectiveness and comparable efficacy to potassium-competitive acid blockers (PCABs). Conversely, Dr. Paul Moayyedi from McMaster University emphasizes the necessity of PCABs for certain patients, particularly those with severe conditions or H. pylori infections. Explore the contrasting viewpoints and the audience's divided opinions on the future of acid suppression therapy.
May 13th, 2025
Read more
© 2025 Wolters Kluwer. All right reserved.